Average Co-Inventor Count = 2.05
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (14 from 1,971 patents)
14 patents:
1. 8053408 - Methods for treating obesity using fibroblast growth factor-like polypeptides
2. 8044024 - Identifying modulators of fibroblast growth factor-like polypeptides
3. 8030275 - Methods for treating obesity using fibroblast growth factor-like polypeptides
4. 7887799 - Antibodies to fibroblast growth factor-like polypeptides
5. 7879323 - Antibodies to fibroblast growth factor-like polypeptides
6. 7727742 - Nucleic acid molecules encoding fibroblast growth factor-like polypeptides
7. 7704952 - Methods for treating diabetes using fibroblast growth factor-like polypeptides
8. 7700558 - Methods for treating diabetes using fibroblast growth factor-like polypeptides
9. 7696172 - Fibroblast growth factor-like polypeptides
10. 7695938 - Vectors and recombinant host cells comprising nucleic acid molecules encoding Fibroblast Growth Factor-like polypeptides
11. 7671180 - Fibroblast growth factor-like polypeptides and variants thereof
12. 7667008 - Fibroblast growth factor-like polypeptides and variants thereof
13. 7459540 - Fibroblast growth factor-like polypeptides
14. 7408047 - Fibroblast growth factor-like polypeptides